Global Lifestyle Drugs Market 2017-2021 , has been prepared based on an in-depth market analysis with inputs from industry experts . This report covers the market landscape and its growth prospects over the coming years . The report also includes a discussion of the key vendors operating in this market .
Inquire for discount at http :// www . reportsnreports . com / contacts / discount . aspx ? name = 917357
Further , the report states that one challenge in the market is the patent expiries . The market is currently dominated by key drugs , namely Cymbalta by Eli Lilly , Abilify by Bristol Myers Squibb ( BMS ), Cialis ( tadalafil ) by Eli Lilly , Staxyn / Levitra ( vardenafil ) by Bayer , and Viagra ( sildenafil citrate ) by Pfizer . The depression drugs such as Cymbalta witnessed a patent expiry in 2013 . Due to the patent expiry , Cymbalta reported a YoY decline of 36.36 % in 2015 . Also , Abilify reported a YoY decline of 63.07 % in 2015 due to patent expiration in the US and EU . In addition , the erectile dysfunction drugs Viagra ( approved in 1998 ), Cialis ( approved in 2003 ), Staxyn / Levitra ( approved in 2003 ) drugs were approved long back , and their patents are nearing expiration in the next few years .
About Us :
ReportsnReports . com is your single source for all market research needs . Our database includes 500,000 + market research reports from over 100 + leading global publishers & in-depth market research studies of over 5000 micro markets . With comprehensive information about the publishers and the industries for which they publish market research reports , we help you in your purchase decision by mapping your information needs with our huge collection of reports .